Key stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about Pfizer
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Pfizer has provided its full-year 2024 guidance, expecting revenues in the range of $58.5 to $61.5 billion, including $8 billion from Comirnaty and Paxlovid, and $3.1 billion from the Seagen acquisition. The company anticipates 8%-10% operational revenue growth excluding COVID-19 products and Seagen, and a cost reduction of at least $4 billion by the end of 2024[1][2].
Pfizer reported strong third-quarter 2024 results and raised its 2024 guidance. The European Commission approved Pfizer’s HYMPAVZI™ for the treatment of adults and adolescents with severe hemophilia A or B without inhibitors. The U.S. FDA also approved Pfizer’s RSV vaccine ABRYSVO® for adults aged 18 to 59 at increased risk for the disease[5].
Pfizer introduced PfizerForAll, a digital platform designed to simplify access to healthcare and manage health and wellness more seamlessly for people across the U.S., aiming to improve the entire healthcare journey from start to finish[4].
Open job positions at Pfizer
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Supervisor/TL, Production- 3rd Shift, Variable Schedule
Pharmacist / chemist (m/f/d) as Head of Product and Process Analytics
EG-医学信息沟通专员-VAC疫苗 深圳